Navigation Links
Latest Hyaluronic Acid Filler Takes the Sting Out of Beauty
Date:7/10/2008

N. DALLAS and PLANO, Texas, July 10 /PRNewswire/ -- In the war of the injectable beauty fillers, the battle will soon become heated with the arrival of the newest hyaluronic acid injectable gel filler in the U.S. aesthetics market. Anika Therapeutics' FDA-approved ELEVESS(TM) enters the arena with a clear combat advantage: incorporation of lidocaine with their hyaluronic acid (H.A.) gel, to improve injection comfort.

Many cosmetic physicians, including Jeffrey Adelglass, MD, FACS of SKINTASTIC(TM) Medical & Surgical Rejuvenation Center of Plano, Texas routinely mix lidocaine with some dermal fillers, or inject lidocaine as a nerve-block prior to filler injection, primarily in sensitive, nerve-rich areas such as the lips and eye areas. Elimination of mixing and nerve-blocks saves time and work for the doctor, and reduces the patient's wait.

Although not the first FDA-approved hyaluronic acid filler/lidocaine formulation in the U.S., ELEVESS(TM) claims to provide long-lasting results. Lack of durability is a chief complaint of frequent H.A. filler users. Currently approved for sale in the U.S., European Union and in Canada, ELEVESS(TM) utilizes a proprietary cross-linking technology that creates a highly-concentrated H.A. formulation which suggests the potential of longer durability in the body. Allergan, the makers of Botox(R), currently produce Juvaderm(R) with lidocaine for the European Union, but U.S. approval of their H.A./lidocaine formulation is forthcoming. A U.S. dermal filler already utilizing lidocaine is non-resorbable-ArteFill (a non-H.A. filler) by Artes Medical; Artes was chosen by Anika Therapeutics to be a U.S. distributor for ELEVESS(TM). Dr. Adelglass is a clinical researcher for Artes Medical, and serves on Artes' Scientific Advisory Board.

Experience counts. Dr. Adelglass was the first Texas physician to recently achieve simultaneous Diamond pinnacle-level status as a Botox(R) injector and Triple-Platinum status with Medicis, the makers of Restylane(R) and Perlane(R) injectable H.A. fillers. Dr. Adelglass is a member of the Star Program-a select group of cosmetic physicians specially-trained to work with new Evolence(R) collagen filler, and is an exclusive Black Card member of Radiesse(R) physician injectors. He serves on the scientific advisory boards of most, if not all U.S. dermal filler companies, and on the National Education Foundation for Allergan, instructing other cosmetic physicians to safely administer Botox(R) using his well-honed injection techniques. Dr. Adelglass is also an official training instructor for SmartLipo(TM) laser body sculpting, the DOT Fractional skin resurfacing laser, ArteFill(R) non- resorbable, and Juvederm(R) fillers. With his level of experience, it's no wonder that many of the representatives of these companies, with all their available options, select Dr. Adelglass as their own cosmetic physician of choice.

The cost of ELEVESS(TM) is expected to be comparable to that of other popular hyaluronic acid fillers. Call (972) 620-3223 to be added to a waiting list to receive a complimentary ELEVESS(TM) evaluation (and special introductory offer). ELEVESS(TM)-related questions can be directed to skintastic@skintastic.com. Skintastic is located in the Presbyterian Plano Center for Diagnostics and Surgery at 6020 W. Parker, Suite 400 in Plano, Texas.


'/>"/>
SOURCE SKINTASTIC(TM) Medical and Surgical Rejuvenation Center
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Licensed Rx Announces Latest Customer Savings Scheme
2. Lifeclinic to Feature Latest Health Stations at McKesson's Pharmacy of the Future
3. Latest Research Shows Strong Consumer Demand for Organic Foods
4. Cardiologist Praises Latest Resveratrol/Red Wine Research
5. The DataTrace(R) RF System, the Latest High Performance Radio Data Logger for Real-Time, Process Data Collection, Reporting, and Analysis Is Launched
6. Agilysys Announces Latest Version of Lodging Management System(R) (LMS)
7. Cardiva Medical, Inc. to Present at the Investment In Innovation (In3) Medical Device Summit on June 18, 2008 in San Francisco, CA; Announces the Completion of Its Latest Phase in Its US Sales Force Expansion
8. Latest research on allergies: Specific immunotherapy can help
9. Service Employee Unions Latest Attack on RNs Parrots McCains Attack on Obamas Health Plan
10. Latest Advances in Infection Prevention and Control to be Presented in Denver, CO at Worlds Largest Annual Infection Prevention Conference, June 15-19, 2008
11. Can SonicMood Help to Significantly Lower High Blood Pressure? The Latest Research Answers With a Resounding YES!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research and ... News Issue 52" report to their offering. ... influenza treatment creates a favourable commercial environment for MedImmune to ... patient base that will serve to drive considerable growth for ... would serve to cap sales considerably, but development is still ...
(Date:6/23/2016)... NORTHBROOK, Ill. and BOGOTA, Colombia , June 23, 2016  Astellas today announced the ... joins Astellas Farma Brasil as the company,s second affiliate in Latin America . ... ... appointed General Manager of Astellas Farma Colombia ... ...
(Date:6/23/2016)... Research and Markets has announced ... Analysis (United States, China, Japan, Brazil, United Kingdom, Germany, ... offering. Surgical Procedure ... planners, provides surgical procedure volume data in a geographic ... in-depth analysis of growth drivers and inhibitors, including world ...
Breaking Medicine Technology: